1. Home
  2. EDSA vs AIHS Comparison

EDSA vs AIHS Comparison

Compare EDSA & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • AIHS
  • Stock Information
  • Founded
  • EDSA 2015
  • AIHS 2014
  • Country
  • EDSA Canada
  • AIHS China
  • Employees
  • EDSA N/A
  • AIHS N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • EDSA Health Care
  • AIHS Finance
  • Exchange
  • EDSA Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • EDSA 13.8M
  • AIHS 11.9M
  • IPO Year
  • EDSA N/A
  • AIHS 2018
  • Fundamental
  • Price
  • EDSA $2.03
  • AIHS $0.32
  • Analyst Decision
  • EDSA Strong Buy
  • AIHS
  • Analyst Count
  • EDSA 2
  • AIHS 0
  • Target Price
  • EDSA $13.00
  • AIHS N/A
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • AIHS 4.2M
  • Earning Date
  • EDSA 08-08-2025
  • AIHS 08-13-2025
  • Dividend Yield
  • EDSA N/A
  • AIHS N/A
  • EPS Growth
  • EDSA N/A
  • AIHS N/A
  • EPS
  • EDSA N/A
  • AIHS N/A
  • Revenue
  • EDSA N/A
  • AIHS $5,878,700.00
  • Revenue This Year
  • EDSA N/A
  • AIHS N/A
  • Revenue Next Year
  • EDSA N/A
  • AIHS N/A
  • P/E Ratio
  • EDSA N/A
  • AIHS N/A
  • Revenue Growth
  • EDSA N/A
  • AIHS 12.21
  • 52 Week Low
  • EDSA $1.55
  • AIHS $0.26
  • 52 Week High
  • EDSA $5.59
  • AIHS $1.70
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • AIHS 30.64
  • Support Level
  • EDSA $1.91
  • AIHS $0.29
  • Resistance Level
  • EDSA $2.14
  • AIHS $0.35
  • Average True Range (ATR)
  • EDSA 0.12
  • AIHS 0.16
  • MACD
  • EDSA 0.02
  • AIHS -0.06
  • Stochastic Oscillator
  • EDSA 64.52
  • AIHS 3.70

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.

Share on Social Networks: